The Oklahoma Department of Corrections is searching for two inmates who unlawfully walked away from a correctional center in Hodgen.
UtmoLight says it has launched the world’s first gigawatt-scale perovskite solar module production line at a facility in Wuxi, China. The plant will annually produce 1.8 million panels, with a target ...
6d
More With Less Today on MSNTJ Maxx Runway - Great Deals on Luxury Items Like Designer Clothing, Shoes, and MoreWhat is the TJ Maxx Runway? Think high-end fashion for less. The Runway section curates authentic designer clothing, shoes, handbags, and accessories from coveted brands like Michael Kors, Kate Spade, ...
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up to 300 beagles per week in Beijing, according to a federal contract ...
The Oxford Avenue project involves consolidating three parcels into a single lot and requires zoning variances to proceed. A six-story self-storage facility has been proposed in Fox Chase. The ...
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the agreement, NAMSA will take ownership of WuXi’s facilities in Minnesota and Georgia.
BEIJING (AP) -- China has executed two men who committed deadly attacks that killed dozens in November and raised concerns about a surge in what are called "revenge on society crimes," state media ...
Also in November, 21-year-old Xu Jiajin killed eight people and injured 17 others in a stabbing attack at his vocational school in the eastern city of Wuxi. Police said Wu had failed his ...
WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...
CAPA publishes more than 1,000 global News Briefs every week, covering all aspects of the aviation and travel industry. It’s the most comprehensive source of market intelligence in the world, with ...
WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results